The roles of pathology in targeted therapy of women with gynecologic cancers

Por Murali, Rajmohan, Grisham, Rachel N., Soslow, Robert A.
Publicado no Gynecol Oncol (2017)

Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer

Por Grisham, Rachel N, Berek, Jonathan, Pfisterer, Jacobus, Sabbatini, Paul
Publicado em 2011

Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management

Por Grisham, Rachel, Ky, Bonnie, Tewari, Krishnansu S., Chaplin, David J., Walker, Joan
Publicado no Gynecol Oncol Res Pract (2018)

Competitive Translation Efficiency at the Picornavirus Type 1 Internal Ribosome Entry Site Facilitated by Viral cis and trans Factors

Por Dobrikova, Elena Y., Grisham, Rachel N., Kaiser, Constanze, Lin, Jennifer, Gromeier, Matthias
Publicado em 2006

Infertility and Male Mating Behavior Deficits Associated With Pde1c in Drosophila melanogaster

Por Morton, David B., Clemens-Grisham, Rachel, Hazelett, Dennis J., Vermehren-Schmaedick, Anke
Publicado em 2010

Mutations in ap1b1 Cause Mistargeting of the Na(+)/K(+)-ATPase Pump in Sensory Hair Cells

Por Clemens Grisham, Rachel, Kindt, Katie, Finger-Baier, Karin, Schmid, Bettina, Nicolson, Teresa
Publicado em 2013

Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience

Por Rubinstein, Maria, Halpenny, Darragh, Makker, Vicky, Grisham, Rachel N., Aghajanian, Carol, Cadoo, Karen
Publicado no Gynecol Oncol Rep (2019)

Synaptic transmission in neurons that express the Drosophila atypical soluble guanylyl cyclases, Gyc-89Da and Gyc-89Db, is necessary for the successful completion of larval and adu...

Por Morton, David B., Stewart, Judith A., Langlais, Kristofor K., Clemens-Grisham, Rachel A., Vermehren, Anke
Publicado em 2008

Gemcitabine for Advanced Endometrial Cancer: A Review of the MSKCC Experience

Por Grisham, Rachel Nicole, Adaniel, Christina, Hyman, David, Ma, Weining, Iasonos, Alexia, Aghajanian, Carol, Konner, Jason
Publicado em 2012

Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation()

Por Martin, Madhuri, Grisham, Rachel N., Turashvili, Gulisa, Halpenny, Darragh F., Aghajanian, Carol A., Makker, Vicky
Publicado no Gynecol Oncol Rep (2017)

Corrigendum to “Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation” [Gynecol. Oncol. Rep. 22 (2017) 9–12]

Por Martin, Madhuri, Grisham, Rachel N., Turashvili, Gulisa, Halpenny, Darragh F., Aghajanian, Carol A., Makker, Vicky
Publicado no Gynecol Oncol Rep (2017)

Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers

Por Hyman, David M., Zhou, Qin, Arnold, Angela G., Grisham, Rachel N., Iasonos, Alexia, Kauff, Noah D., Spriggs, David
Publicado em 2011

BRAF(V600E) mutations and immunohistochemical expression of VE1 protein in low-grade serous neoplasms of the ovary

Por Turashvili, Gulisa, Grisham, Rachel N., Chiang, Sarah, Delair, Deborah F., Park, Kay J., Soslow, Robert A., Murali, Rajmohan
Publicado no Histopathology (2018)

Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models

Por Wise, Hannah C., Iyer, Gopakumar V., Moore, Kathleen, Temkin, Sarah M., Gordon, Sarah, Aghajanian, Carol, Grisham, Rachel N.
Publicado no Sci Rep (2019)

Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer

Por Grisham, Rachel N., Iyer, Gopa, Sala, Evis, Zhou, Qin, Iasonos, Alexia, DeLair, Deborah, Hyman, David M., Aghajanian, Carol
Publicado no Int J Gynecol Cancer (2014)

Phase Ib Study of Binimetinib with Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer: Final Results, Potential Biomarkers, and Extreme Responders

Por Grisham, Rachel N., Moore, Kathleen N., Gordon, Michael S., Harb, Wael, Cody, Gwendolyn, Halpenny, Darragh F., Makker, Vicky, Aghajanian, Carol A.
Publicado no Clin Cancer Res (2018)

Tip-link protein protocadherin 15 interacts with transmembrane channel-like proteins TMC1 and TMC2

Por Maeda, Reo, Kindt, Katie S., Mo, Weike, Morgan, Clive P., Erickson, Timothy, Zhao, Hongyu, Clemens-Grisham, Rachel, Barr-Gillespie, Peter G., Nicolson, Teresa
Publicado em 2014

Tumor Inhibition by Enzalutamide in a Xenograft Model of Ovarian Cancer

Por Park, Brian Y., Grisham, Rachel N., den Hollander, Bjørnar, Thapi, Dharmarao, Berman, Tara, de Stanchina, Elisa, Zhou, Qin, Iyer, Gopa, Aghajanian, Carol, Spriggs, David R.
Publicado no Cancer Invest (2016)

CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas

Por Nougaret, Stephanie, Lakhman, Yulia, Molinari, Nicolas, Feier, Diana, Scelzo, Chiara, Vargas, Hebert A., Sosa, Ramon E., Hricak, Hedvig, Soslow, Robert A., Grisham, Rachel N., Sala, Evis
Publicado no AJR Am J Roentgenol (2018)

Outcomes of Primary Surgical Cytoreduction in Patients with BRCA-associated High-grade Serous Ovarian Carcinoma

Por Hyman, David M., Long, Kara C., Tanner, Edward J., Grisham, Rachel N., Arnold, Angela G., Bhatia, Jasmine, Phillips, Mary F., Spriggs, David R., Soslow, Robert A., Kauff, Noah D., Levine, Douglas A.
Publicado em 2012